🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. VX-880

    Vertex Pharmaceuticals (Australia) Pty.

    Diabetes Mellitus, Type 1

    phase 3 mab active

    1 trial

  2. VX-880 solution for infusion

    Vertex Pharmaceuticals (Australia) Pty.

    Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia

    phase 3 small molecule active

    1 trial

  3. Vehicle to Mecloderm Ointment, LOTRICOMB® Salbe, 0,64 mg/g + 10 mg/g, Salbe, Mecloderm Ointment

    Alphapharm Pty Ltd

    moderate to severely inflamed candidiasis of the skin

    phase 3 small molecule active

    1 trial

  4. Vehicle to Test Product, Ivermectin Cream, Soolantra 10 mg/g Creme

    Alphapharm Pty Ltd

    Papulopustular Rosacea

    phase 3 small molecule active

    1 trial

  5. Veligrotug

    Viridian Pharma Ltd

    Thyroid Eye Disease

    phase 3 small molecule completed

    1 trial

  6. Veligrotug (VRDN-001)

    Viridian Pharma Ltd

    Thyroid Eye Disease

    phase 3 small molecule completed

    1 trial

  7. Venclexta, Venclyxto, Levact 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Venclexta, Venclyxto, Fludarabinphosphat "Ebewe", koncentrat til injektions-/infusionsvæske, opløsning, Venclexta, Venclyxto, Fludarabin Ebewe 25 mg/ml injektio-/infuusiokonsentraatti, liuosta varten, Fludarabin Sandoz 25 mg/ml injekčný alebo infúzny koncentrát, MabThera 500 mg concentrate for solution for infusion, Levact 2,5 mg/ml poudre pour solution à diluer pour perfusion, Bendamustin cell pharm® 2,5

    Hoffmann-La Roche

    Chronic Lymphocytic Leukemia (CLL)

    phase 3 small molecule active

    1 trial

  8. Venofer 20 mg iron / ml, solution for injection or concentrate for solution for infusion., Ferumoxytol

    Lacuna Pharma Pty Ltd

    Iron Deficiency Anemia (IDA)

    phase 3 small molecule active

    1 trial

  9. Venofer 20 mg iron / ml, solution for injection or concentrate for solution for infusion., Ferumoxytol

    Lacuna Pharma Pty Ltd

    Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)

    phase 3 small molecule active

    1 trial

  10. Venofer 200 MG Per 10 ML Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Iron Deficiency Anemia of Pregnancy

    phase 3 small molecule active

    1 trial

  11. Ventricular Assist Device System

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 3 other completed

    1 trial

  12. Vibegron, Vibegron, Vibegron, Vibegron, Vibegron, Vibegron, Vibegron

    Lacuna Pharma Pty Ltd

    Neurogenic Detrusor Overactivity (NDO)

    phase 3 small molecule active

    1 trial

  13. Vidaza 25 mg/ml powder for suspension for injection, Gilteritinib

    Astellas Pharma GmbH

    Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Induction Chemotherapy

    phase 3 small molecule active

    1 trial

  14. Vildagliptin

    Novartis Pharmaceuticals

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  15. Vildagliptin

    Novartis Pharmaceuticals

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  16. Viltolarsen

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy (DMD)

    phase 3 small molecule active

    1 trial

  17. Voclosporin

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule completed

    3 trials

  18. Voclosporin

    Aurinia Pharmaceuticals

    Adolescent Lupus Nephritis

    phase 3 small molecule terminated

    2 trials

  19. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Familial Chylomicronemia Syndrome

    phase 3 small molecule completed

    2 trials

  20. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Hypertriglyceridemia

    phase 3 small molecule completed

    1 trial

  21. Vonoprazan

    Phathom Pharmaceuticals

    Helicobacter Pylori Infection

    phase 3 small molecule completed

    1 trial

  22. Vonoprazan

    Phathom Pharmaceuticals

    Erosive Esophagitis

    phase 3 small molecule completed

    2 trials

  23. Vonoprazan

    Phathom Pharmaceuticals

    Non-Erosive Gastro-Esophageal Reflux Disease

    phase 3 small molecule completed

    2 trials

  24. Vosoritide

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources